FDA Warning Letter — Abrams Royal Pharmacy

Case 428466 — FEI 1000138425

The FDA took a Warning Letter action against Abrams Royal Pharmacy on July 14, 2014 (Dallas, TX). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
Abrams Royal Pharmacy
Date
July 14, 2014
Fiscal Year
2014
Product Type
Drugs
Center
CDER
Location
Dallas, TX (United States)